Acasti pharma to present at the h.c. wainwright bioconnect 2022 conference

Laval, quÉbec, jan. 03, 2022 (globe newswire) -- acasti pharma inc. (“acasti” or the “company”) (nasdaq: acst and tsx-v: acst), today announced that jan d'alvise, president and ceo of acasti, will be presenting at the h.c. wainwright bioconnect 2022 conference being held virtually january 10-13, 2022.

ACST Ratings Summary

ACST Quant Ranking